Sotera Health (NYSE:SHC) Shares Gap Up to $6.02

Shares of Sotera Health (NYSE:SHCGet Rating) gapped up prior to trading on Monday . The stock had previously closed at $6.02, but opened at $7.25. Sotera Health shares last traded at $9.15, with a volume of 186,674 shares changing hands.

Analysts Set New Price Targets

SHC has been the subject of several research analyst reports. Barclays downgraded shares of Sotera Health from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $7.00 to $6.00 in a research note on Tuesday, November 15th. The Goldman Sachs Group downgraded shares of Sotera Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $23.00 to $9.00 in a research note on Tuesday, September 20th. TheStreet downgraded shares of Sotera Health from a “c-” rating to a “d” rating in a research note on Monday, September 19th. Royal Bank of Canada decreased their price target on shares of Sotera Health from $25.00 to $8.00 and set an “outperform” rating for the company in a research note on Thursday, November 3rd. Finally, Citigroup downgraded shares of Sotera Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $25.00 to $9.00 in a research note on Wednesday, October 5th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Sotera Health presently has an average rating of “Hold” and a consensus price target of $16.00.

Sotera Health Trading Down 0.2 %

The company has a quick ratio of 2.74, a current ratio of 3.00 and a debt-to-equity ratio of 2.97. The firm’s 50-day moving average price is $7.46 and its 200 day moving average price is $15.19. The company has a market capitalization of $2.25 billion, a P/E ratio of 8.99 and a beta of 1.27.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. New York State Common Retirement Fund boosted its holdings in Sotera Health by 7.9% during the first quarter. New York State Common Retirement Fund now owns 151,959 shares of the company’s stock worth $3,291,000 after purchasing an additional 11,174 shares during the last quarter. Verition Fund Management LLC purchased a new position in Sotera Health during the first quarter worth about $3,693,000. Crossmark Global Holdings Inc. boosted its holdings in Sotera Health by 25.5% during the second quarter. Crossmark Global Holdings Inc. now owns 22,660 shares of the company’s stock worth $444,000 after purchasing an additional 4,600 shares during the last quarter. Texas Permanent School Fund purchased a new position in Sotera Health during the second quarter worth about $939,000. Finally, Comerica Bank purchased a new position in Sotera Health during the second quarter worth about $851,000. 88.38% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Company Profile

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Further Reading

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.